Cytori Therapeutics, Inc. (CYTX) Reports In-Line Q1 Loss of 16c/Share
Tweet Send to a FriendGet Alerts CYTX Hot Sheet
Price: $2.63 -0.75%
EPS Growth %: +50.0%
Financial Fact:
Total Development Revenues: 2.37M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: +50.0%
Financial Fact:
Total Development Revenues: 2.37M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade CYTX Now!
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $1.48 million, versus $1.36 million reported last year.
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Macy's (M) Posts Q1 EPS of 55c; Comps Up 3.8%; Boosts Dividend 25%, Raises Buyback
- J.C. Penney Co., Inc. (JCP) Posts Q1 Loss of $1.31/Share; Comps Down 16.6%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
